Investors & Media

COMING SOON…

ABOUT US

Leveraging next-generation
antimicrobials to address significant
unmet medical needs in the treatment
of serious infectious diseases,
improving patient outcomes and
significantly reducing the urgent
threats posed by increasingly
antibiotic-resistant bacterial strains.

CONTACT US

Lakewood-Amedex, Inc.
3030 University Parkway
Sarasota, FL 34243
Main: (941) 225-2515

Privacy Policy

NEWSROOM

Lakewood-Amedex Therapeutics Announces the Election of Peter B. Corr, Ph.D., as Chairman of the Board of Directors July 21, 2020
Lakewood-Amedex Receives Notice of Allowance for Two U.S. Patents Covering the Broad-Spectrum Antimicrobial Nu-8 Bisphosphocin® May 27, 2020
Lakewood-Amedex Prepares to Launch a Phase 2 cDFU Clinical Trial for Its Nu-3 Antimicrobial in The Bahamas January 17, 2019